Literature DB >> 12225356

A sense of tumour for the immune system.

Stephen Todryk1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225356      PMCID: PMC1782779          DOI: 10.1046/j.1365-2567.2002.01506.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  22 in total

1.  Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.

Authors:  Janice M Kelly; Phillip K Darcy; Jessica L Markby; Dale I Godfrey; Kazuyoshi Takeda; Hideo Yagita; Mark J Smyth
Journal:  Nat Immunol       Date:  2001-12-17       Impact factor: 25.606

2.  Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression.

Authors:  A Melcher; S Todryk; N Hardwick; M Ford; M Jacobson; R G Vile
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

Review 3.  An innate sense of danger.

Authors:  P Matzinger
Journal:  Semin Immunol       Date:  1998-10       Impact factor: 11.130

Review 4.  Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world.

Authors:  P K Srivastava; A Menoret; S Basu; R J Binder; K L McQuade
Journal:  Immunity       Date:  1998-06       Impact factor: 31.745

Review 5.  Cancer vaccines.

Authors:  D M Pardoll
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

6.  Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells.

Authors:  J Gong; D Chen; M Kashiwaba; D Kufe
Journal:  Nat Med       Date:  1997-05       Impact factor: 53.440

Review 7.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Authors:  S Sakaguchi; N Sakaguchi; J Shimizu; S Yamazaki; T Sakihama; M Itoh; Y Kuniyasu; T Nomura; M Toda; T Takahashi
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

8.  Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.

Authors:  F O Nestle; S Alijagic; M Gilliet; Y Sun; S Grabbe; R Dummer; G Burg; D Schadendorf
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

9.  Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

Authors:  A Y Huang; P Golumbek; M Ahmadzadeh; E Jaffee; D Pardoll; H Levitsky
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

Review 10.  Immunotherapeutic potential of whole tumour cells.

Authors:  Stephen Ward; David Casey; Marie-Christine Labarthe; Michael Whelan; Angus Dalgleish; Hardev Pandha; Stephen Todryk
Journal:  Cancer Immunol Immunother       Date:  2002-06-14       Impact factor: 6.968

View more
  2 in total

1.  Nicotine has suppressive effects on dendritic cell function.

Authors:  Nancy Hogg
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

2.  Lentiviral vector-based therapy in head and neck cancer (Review).

Authors:  Deepak Upreti; Alok Pathak; Sam K P Kung
Journal:  Oncol Lett       Date:  2013-11-01       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.